Personalised Medicines & Biomarkers 2015

Topics

• Biomarker discovery & validation
• Visionaries of Personalised Medicine
• Personalised Medicine in the USA,EU
• Government policies & strategies
• Changing the business model to integrate personalised medicine
• Novel Applications for personalised medicine
• Discovering successful business models
• Can we streamline the commercialization process?
• Learn about the latest findings in genomics and how to apply them to your practice
• Opportunities & Challenges
• Development and application of clinical safety biomarkers with a focus on imaging biomarkers
• Learn practical applications for integrating genomics and pharmacogenomics to individualize patient care
• Discuss how to disseminate genomic information to patients through ethical, legal and regulatory frameworks
• Discuss strategies to overcome obstacles of implementing genomic sequencing for patient care
• Technology & Point of Care
• Companion diagnostics & Personalised medicine
• How biomarkers can accelerate your clinical development
• Safety & Biomarkers in clinical development
• Design strategies for success in early phase trials
• Enabling technologies to maximise biomarker identification
• Showing clinical utility of biomarkers to improve diagnosis & make informed decision making
• Inflammatory / Immunological, Neurological, Oncology Biomarkers
• Analyze biomarkers and their role in drug development
• See how improvements in technologies are leading to better efficiency of biomarkers
• Identifying current developments in biomarkers & ways to overcome threats
• Assess preclinical safety considerations
• Network in our combined exhibition and catering area
• Emerging stratified medicine via successful partnerships
• Evening networking reception for all attendees

Who should Attend

• Diagnostic/Analytics Company Leaders
• Pharmaceutical Company Leaders
• CRO
• Biotechnology
• Genome Interpretation Experts
• Medical/Diagnostics Laboratories, Consulting, Biobanks
• Biotech Leaders
• Genome Sequencing Pioneers
• Consultants
• Healthcare Providers
• Government Leaders
• Doctors & Pharmacists
• Investors
• Health Insurance Executives
• Oncology
• Biomarkers Pharmacogenomics
• Epigenetics
• Molecular Biology
• Clinical Oncology
• Clinical Pharmacology Statistical Biomarkers
• Discovery Medicine
• Proteomics
• Experimental Medicine
• Clinical and Translational Research
• CNS
• Systems Biology
• Regulation
• Toxicity
• Genomic
• PK/PD
• Molecular Informatics
• Pharmacogenetics
• MicroRNA
• Neurology
• Imaging